The Markethaven Sponsor Notice was issued by the TGA from its Canberra offices to Markethaven at its premises in Queensland. Mr Dallen deposes to the fact that, since submissions on the Commonwealth's application were heard in March 2009, two new Federal Court proceedings against the Commonwealth and the personal respondents in relation to the suspension of the licence of Pan to manufacture therapeutic goods under the Therapeutic Goods Act had been commenced in the New South Wales District Registry of this Court. Relevant matters 1. (7) The representative proceeding is being funded by IMF (Australia) Ltd ("IMF").